<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10-ijms-21-09049">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shirakawa</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Man</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Maksimoska</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Sorum</surname>
    <given-names>A.W.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>H.W.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>I.S.</given-names>
   </name>
   <name>
    <surname>Shimazu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Newman</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Schr√∂der</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity</article-title>
  <source>eLife</source>
  <year>2016</year>
  <volume>5</volume>
  <fpage>e11156</fpage>
  <pub-id pub-id-type="doi">10.7554/eLife.11156</pub-id>
  <pub-id pub-id-type="pmid">27244239</pub-id>
 </element-citation>
</ref>
